Clinical trial
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol…
NCT00204074 · University Hospital, Linkoeping, Other · Unknown status
Key facts
| NCT number | NCT00204074 |
|---|---|
| Title | Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial. |
| Lead sponsor | University Hospital, Linkoeping, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | 17-beta-estradiol (drug) |
| Start date | Oct 1, 2001 |
| Completion | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 29, 2005 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: